HRP Anti-CPT1A antibody [8F6AE9]
- BOND RX™ Validated
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Mouse Monoclonal CPT1A antibody - conjugated to HRP. Suitable for IHC-P, WB and reacts with Human, Rat samples. Cited in 2 publications.
View Alternative Names
CPT1, CPT1A, CPT1-L, Carnitine palmitoyltransferase 1A, Succinyltransferase CPT1A, CPT I, CPTI-L
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-CPT1A antibody [8F6AE9] (AB198494)
IHC image of CPT1A staining in a section of formalin-fixed paraffin-embedded normal human colon tissue*, performed on a Leica BOND. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab198494 at 1/100 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - HRP Anti-CPT1A antibody [8F6AE9] (AB198494)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab198494 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-CPT1A antibody [8F6AE9] (ab198494) at 1/5000 dilution
Lane 1:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 20 µg
Lane 2:
Heart (Human) Tissue Lysate - adult normal tissue at 20 µg
Lane 3:
Liver (Rat) Tissue Lysate at 20 µg
Predicted band size: 88 kDa
Observed band size: 88 kDa
true
Exposure time: 1min
- WB
Lab
Western blot - HRP Anti-CPT1A antibody [8F6AE9] (AB198494)
Lanes 1 - 4 : Merged signal (red and green). Green - ab198494 observed at 88 kDa. Red - loading control, ab181602, observed at 37 kDa.
ab198494 was shown to specifically react with in wild-type HAP1 cells as signal was lost in CPT1A knockout cells. Wild-type and CPT1A knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% NF Milk. ab198494 and ab181602 (Rabbit anti-GAPDH loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/20000 dilution respectively. The loading control was imaged using the Licor Odyssey CLx prior to blots being developed with ECL technique.
All lanes:
Western blot - HRP Anti-CPT1A antibody [8F6AE9] (ab198494) at 1/5000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
CPT1A knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MCF7 whole cell lysate at 20 µg
Predicted band size: 88 kDa
Observed band size: 88 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CPT1A antibody [8F6AE9]
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CPT1A plays a vital role in energy production by facilitating mitochondrial fatty acid oxidation. It does not function as a solitary enzyme but often associates with other enzymes forming a multiprotein complex that includes acyl-CoA synthetase. This complex enables efficient fatty acid transport and oxidation converting stored fats into usable energy. As CPT1A primarily operates in the liver its activity significantly impacts overall lipid and energy homeostasis demonstrating its critical regulatory role.
Pathways
CPT1A is central to the fatty acid beta-oxidation pathway an important process for breaking down fatty acids to produce energy. This pathway also involves proteins such as CPT1B a related isoform present in muscle tissues. CPT1A's function is important in the liver's capacity to regulate energy balance and respond to metabolic demands. Additionally CPT1A interacts within the signaling pathway of AMPK (AMP-activated protein kinase) which further integrates it into broader metabolic regulation networks linking energy status to cellular function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Experimental and therapeutic medicine 17:1863-1869 PubMed30783461
2019
Applications
Unspecified application
Species
Unspecified reactive species
Biochimica et biophysica acta. Molecular basis of disease 1865:147-160 PubMed30404040
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com